{"id":372346,"title":"Notice: Prescription Drug List (PDL): Naloxone - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T16:41:39.130000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/notice-prescription-drug-list-naloxone.html","snippet":"Notice: Prescription Drug List (PDL): Naloxone January 14, 2016 Our file number: 16-100479-342 The purpose of this Notice of Consultation is to provide an opportunity to comment on the proposal to revise the listing for Naloxone on the Prescription Drug List (PDL) to allow the…","rawSnapshotUrl":"/api/snapshots/raw/372346","browseUrl":"https://replay.healtharchive.ca/job-6/20260411164139/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/notice-prescription-drug-list-naloxone.html#ha_snapshot=372346","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}